Sponsor

Henan Genuine Biotech Co., Ltd.

Clinical research sponsor

Published trials6

Recruiting shown3

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

A Phase Ⅱa Clinical Study of CL-197 CapsulesNCT07308782 · lead sponsor · 2025-11-29

RECRUITING

A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With DositinibNCT07362940 · lead sponsor · 2025-11-27

RECRUITING

A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR MutationNCT07231068 · lead sponsor · 2022-10-31

RECRUITING

A Study of CL-197 Capsules in Healthy ParticipantsNCT05944848 · lead sponsor · 2022-11-16

COMPLETED

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive PatientsNCT04303598 · lead sponsor · 2020-04-01

UNKNOWN

A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV TreatmentNCT04109183 · lead sponsor · 2017-10-10

COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.